The association between Acinetobacter baumannii infections and the COVID-19 pandemic in an intensive care unit.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
02 12 2022
02 12 2022
Historique:
received:
04
10
2022
accepted:
30
11
2022
entrez:
2
12
2022
pubmed:
3
12
2022
medline:
7
12
2022
Statut:
epublish
Résumé
We aimed to describe the increased rate of Acinetobacter baumannii infections during the COVID-19 pandemic and define its significance within the last five years. This study was performed in a tertiary hospital with 280 beds and included all patients infected with A. baumannii in the intensive care unit between January 1, 2018, and June 30, 2022. A. baumannii-infected patients in the intensive care unit 27 months before the pandemic and 27 months during the pandemic were included. Pulsed-field gel electrophoresis was performed to assess clonal relatedness. The infection control measures were specified based on the findings and targeted elimination. In total, 5718 patients were admitted to the intensive care unit from January 1st, 2018, to June 30th, 2022. A. baumannii infection was detected in 81 patients. Compared to the pre-pandemic era, the rate of A. baumannii infection during the pandemic was 1.90 times higher (OR: 1.90, 95% CI: [1.197, 3.033]). Clonality assessment of multidrug-resistant A. baumannii samples revealed eight clusters with one main cluster comprising 14/27 isolates between 2021 and 2022. The case fatality rate of the pre-pandemic and pandemic era was not different statistically (83.33% vs. 81.48%, p = 0.835). Univariate analysis revealed the association of mechanical ventilation (p = 0.002) and bacterial growth in tracheal aspirate (p = 0.001) with fatality. During the COVID-19 pandemic, potential deficits in infection control measures may lead to persistent nosocomial outbreaks. In this study, the introduction of enhanced and customized infection control measures has resulted in the containment of an A. baumannii outbreak.
Identifiants
pubmed: 36460749
doi: 10.1038/s41598-022-25493-8
pii: 10.1038/s41598-022-25493-8
pmc: PMC9716169
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20808Informations de copyright
© 2022. The Author(s).
Références
Sci Rep. 2019 May 20;9(1):7600
pubmed: 31110214
Am J Infect Control. 2021 May;49(5):653-654
pubmed: 33011335
Infect Control Hosp Epidemiol. 2022 Jun;43(6):815-817
pubmed: 33685542
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Antimicrob Resist Infect Control. 2022 Jan 21;11(1):12
pubmed: 35063032
Infect Prev Pract. 2020 Jul 19;2(3):100077
pubmed: 34368717
Dtsch Arztebl Int. 2010 May;107(21):361-7
pubmed: 20539810
Microorganisms. 2022 Mar 28;10(4):
pubmed: 35456774
PLoS One. 2014 Dec 26;9(12):e115969
pubmed: 25541711
Pathogens. 2021 Aug 10;10(8):
pubmed: 34451470
BMC Infect Dis. 2020 Jan 30;20(1):92
pubmed: 32000693
J Clin Microbiol. 2005 Sep;43(9):4328-35
pubmed: 16145073
J Hosp Infect. 2020 Aug;105(4):643-647
pubmed: 32585172
Int J Infect Dis. 2022 Jan;114:11-14
pubmed: 34653659
J Glob Antimicrob Resist. 2021 Mar;24:136-147
pubmed: 32889142
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
MMWR Morb Mortal Wkly Rep. 2020 Dec 04;69(48):1827-1831
pubmed: 33270611
Eur J Clin Microbiol Infect Dis. 2021 Aug;40(8):1737-1742
pubmed: 33586014
J Int Med Res. 2020 Aug;48(8):300060520949766
pubmed: 32820692
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Infection. 2022 Feb;50(1):83-92
pubmed: 34176088
Clin Microbiol Rev. 2017 Jan;30(1):409-447
pubmed: 27974412
J Hosp Infect. 2009 Dec;73(4):378-85
pubmed: 19726106
Infect Prev Pract. 2021 Mar;3(1):100113
pubmed: 34316574
Intensive Care Med. 2021 Feb;47(2):188-198
pubmed: 33388794
BMC Infect Dis. 2020 Sep 1;20(1):646
pubmed: 32873235
J Clin Microbiol. 1995 Sep;33(9):2233-9
pubmed: 7494007
Biomolecules. 2020 May 06;10(5):
pubmed: 32384624
Infect Drug Resist. 2018 Aug 21;11:1249-1260
pubmed: 30174448